Dimensional Fund Advisors LP Inmune Bio, Inc. Transaction History
Dimensional Fund Advisors LP
- $449 Billion
- Q3 2025
A detailed history of Dimensional Fund Advisors LP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 10,581 shares of INMB stock, worth $15,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,581
Previous 25,139
57.91%
Holding current value
$15,342
Previous $58,000
62.07%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding INMB
# of Institutions
84Shares Held
5.35MCall Options Held
310KPut Options Held
371K-
Vanguard Group Inc Valley Forge, PA876KShares$1.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.18 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$864,73945.87% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$680,6880.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$535,6850.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $26M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...